Otterbein University

Digital Commons @ Otterbein
Nursing Student Class Projects (Formerly MSN)

Student Research & Creative Work

8-1-2019

Helicobacter pylori Pathophysiology
Alisha Smith
Otterbein University, eddy1@otterbein.edu

Follow this and additional works at: https://digitalcommons.otterbein.edu/stu_msn
Part of the Family Practice Nursing Commons, Gastroenterology Commons, and the Pathology
Commons

Recommended Citation
Smith, Alisha, "Helicobacter pylori Pathophysiology" (2019). Nursing Student Class Projects (Formerly
MSN). 383.
https://digitalcommons.otterbein.edu/stu_msn/383

This Project is brought to you for free and open access by the Student Research & Creative Work at Digital
Commons @ Otterbein. It has been accepted for inclusion in Nursing Student Class Projects (Formerly MSN) by an
authorized administrator of Digital Commons @ Otterbein. For more information, please contact
digitalcommons07@otterbein.edu.

Helicobacter pylori Pathophysiology
Alisha Eddy-Smith BSN, SANE, RN
Otterbein University, Westerville, Ohio

Introduction
Helicobacter pylori is a Gramnegative, microaerophilic bacterium
found in the human intestines.
Exposure to the pathogen often occurs
as adolescents by fecal-oral, gastricoral, and oral-oral transmission. Nearly
50% of the population worldwide carry
the pathogen, only 30% of those
develop symptoms (Dionyssios et al,
2015). The pathogen virulence is
determined by the strain and
characteristics. This microorganism
stimulates an immune response leading
to chronic inflammation. Potentially
causing acute or chronic gastritis, peptic
ulcers, gastric adenocarcinoma, gastric
cancer, and lymphomas of the gastric
lymphoid tissue.
Worldwide the third leading cause
of cancer deaths is gastric. H. pylori is
considered a significant etiologic factor
in gastric cancer. Lee et al. (20160
conducted a systematic review and
meta-analysis are to examine the
relationship between H. pylori
eradication and the incidence of gastric
cancer. Lee et al. (2016) concluded that
eradication of H. pylori is associated
with a lower incidence of gastric cancer.
As a future Nurse Practitioner,
screening and prevention is a top
priority. Understanding the
pathophysiology of disorders is crucial
to preventing and managing diseases.

Pathophysiology
H. pylori is helical shaped and has a
sheathed flagella which allows the
bacteria to efficiently travel thru the
intestines (Dionyssios et al, 2015. This
pathogen virulence is assisted by
secreting exotoxins VacA and CagA.
VacA induces mucosal cell apoptosis.
CagA damages the columnar epithelia of
the intestines. Additionally, the
exotoxin promotes inflammation by
stimulating the production of IL-8
which attracts neutrophils. The
inflammatory response results in
gastritis. CagA is associated with
adenocarcinoma and mucosaassociated lymphoid tissue.

Chronic inflammation or edema has the
potential to scar, obstructing flow
between the duodenum and stomach.
Lipopolysaccharides line the exterior,
allowing the pathogen to adhere to cells
and the intestinal wall (Dionyssios et al,
2015. Urease enzyme located on the
pathogen’s surface converts urea to
carbon dioxide and ammonia to create a
more alkaline environment.
Digestion of food is reliant on the
acidic environment created by the goblet
cells. The alkaline environment, flagella,
and helical shape allow the pathogen to
travel thru the gastric layers. It adheres
to the gastric epithelial cells, induces
inflammation, apoptosis, and erodes the
lining. The erosion of the stomach lining
and cellular damage leads to ulcerations
of the duodenum and stomach. Ulcers
have the potential to erode blood vessels
or cause a perforation.

Significance of
Pathophysiology
H. pylori virulence and chronic
inflammation have enormous health
consequences. Considering the
research and health complications,
providers have room to improve
management and surveillance of the
pathogen.
Park et al. (2016) research aim to
provide current evidence of the
prevalence of H. pylori resistance to
clarithromycin in the U.S. This
quantitative research indicates >20%
of H. pylori have developed resistance
to Clarithromycin (MUT 23 rRNA). A
mutation for 23S rRNA domain V was
observed in 32.3% of cases (Park et al.,
2016).

This study reconfirms the importance
of adhering to the American College of
Gastroenterology guidelines, to test,
treat and retest. Murakami et al.
(2017) examined physicians
management of H. pylori. The
research revealed that 58% of
physicians confirmed eradication and
26% “sometimes” confirm posttreatment eradication (Murkami et al.,
2017).
Kim et al. (2014) peer-reviewed
retrospective study is to examine the
rate of H. pylori testing on the
hospitalized patient with confirmed
bleeding ulcers. U.S. and international
guidelines recommend H. pylori
testing on patients with bleeding
ulcers. Researchers conclude less
than half of patients were tested for H.
pylori in hospitalized patients with
bleeding ulcers.
Providers need to increase
surveillance to prevent associated
disorders and significant health
complications for patients.
•

Gastritis main causative agent is
H. pylori (Eda, H. et al., 2017).
CagA stimulation of the
inflammatory process
contributes to gastritis.

•

Peptic Ulcer is closely associated
with H. pylori (Eda, H. et al.,
2017). The erosion of the
mucosa layers and inflammatory
process contribute to ulcer
formation.

•

Case Study
Mr. Smith a 61-year-old male presents
to Urgent care with non-radiating
intermittent epigastric pain, alleviated after
eating and aggravated in the morning,
nausea, heartburn, recent unintentional
weight loss of 8 lbs. in a month, decreased
appetite. Patient reports history of
duodenum ulcer and currently treating with
proton pump inhibitor daily. Family history
of gastric cancer.

Abdominal exam yields palpable
bladder, active, soft, round, non-tender,
no guarding, passing flatus, last bowel
movement today formed. Mr. Smith is
initiated on Zofran for nausea, will
continue on current PPI, educated to
consume 6 small meals daily, add Ensure
protein drinks between meals as
tolerated, and referred to a Gastroenterologist for further evaluation.

Helicobacter Pylori

•

Stomach biopsy is considered the
gold standard, however the most
invasive for diagnosis of H. pylori.

•

Blood antibody test measure H.
pylori IgG specific antigens, with a
sensitivity and specificity rage is
80-95%.

•

Urea breath test is the least
invasive exam, with a specificity of
98% and a sensitivity of 97%.

•

Stool antigen test is a noninvasive
method for HpSA using an enzyme
immunoassay.

Implications for
Nursing Care

Conclusion
In summary, H. pylori virulence is
determined by the immune response,
pathogen characteristics, and the host
environmental conditions. With the
widespread prevalence of this
pathogen, providers must be alert to
the harmful effects.
Providers are responsible for
diagnosing disease, managing, and
seeking out the source. A variety of
disorders have a strong association to
this pathogen. Providers must adhere
to the American College of
Gastroenterologist guidelines to test,
treat, and retest. These efforts to
eradicate the pathogen will prevent
chronic disease, permanent damage,
and death.

Recognition, Diagnosis, and
Surveillance:
- Advanced practice nurse is responsible
for recognizing and diagnosing disease.
•

•
-

-

Education:
A diet plan low in sugar, fat,
irritating foods, caffeine, and
alcohol.
Adhering to medication
Retesting for eradication of the
bacterium
Symptoms requiring further
evaluation
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Gastric cancer develops from
glandular atrophy to chronic
gastritis. H. pylori have a direct
involvement and is recognized as
the leading cause of gastric
cancer (Ki et al., 2014).

Clinical
Manifestations
•
•
•
•
•
•
•
•
•
•
•
•
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Evaluation

Abdominal pain (ache or burning)
aggravated by empty stomach
Fullness or bloating
Weight loss, decreased appetite
Nausea
Vomiting
Heartburn
Shortness of breath
Hematochezia
Hematemesis
Iron deficiency anemia
Abdominal distension
Eructation (burping)

Risk factors
•
•
•

Living in crowded conditions or a
developing country
Contaminated water or food
sources
Being in contact with stool, saliva,
or blood on an infected person

•
-

Medical Management:
Amoxicillin
Clarithromycin
Proton Pump inhibitor
Antiemetic
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